We are pleased to announce that our research paper, titled “Factors Influencing Mortality in COVID-Associated Mucormycosis – The International ID-IRI Study,” has been accepted for publication in the journal Medical Mycology.
List of Authors
Meyha Sahin, Mesut Yilmaz, Ali Mert, Behrouz Naghili, Fatemeh Ravanbakhsh, Mojtaba Varshochi, Ilad Alavi Darazam, Mohammad Javad Ebrahimi, Maral Moafi, Hamed Azhdari Tehrani, Amjad Mahboob, Naveed Rashid, Ejaz Ahmed Khan, Atousa Hakamifard, Gülden Eser-Karlidag, Abdolreza Babamahmoodi, Amani El-Kholy, Sayed Hussain Mosawi, Ayşe Albayrak, Jamal Wadi Al Ramahi, Syam Kumar Addepalli, Şafak Özer Bali Asfandiyar Khan, Nirav Pandya, Esra Gurbuz, Gülden Sincan, Hadia Azami, Rıdvan Dumlu, Reham Khedr, Rezaul Karim Ripon, Sevil Alkan, Şükran Kose, Bahadır Ceylan, Hakan Erdem.
Congratulations to the participants of the study. The key findings are as follows:
Mortality Rates and Risk Factors
The overall mortality rate in the study was 39%. Several risk factors were identified that were associated with higher mortality:
1. Advanced age – Higher age was a significant risk factor, with a Hazard Ratio (HR) of 1.06 (p<0.001).
2. Rituximab use – Use of the medication rituximab was also a major risk factor, with an HR of 21.2 (p=0.05).
3. Diabetic ketoacidosis – Presence of diabetic ketoacidosis increased the mortality risk, with an HR of 3.58 (p=0.009).
Improved Survival
1. Surgical debridement – This surgical procedure was associated with improved survival outcomes.
Infectious Diseases - International Research Initiative (ID-IRI) 